skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
XELOX Regimen (Code C63597)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: XELOX Regimen

Definition: A regimen consisting of capecitabine and oxaliplatin used for the treatment of advanced stage colorectal cancer. This regimen differs from a similar regimen, CAPOX, with regards to the dosing schedule for oxaliplatin.

NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread. It is also being studied in the treatment of other types of cancer. It includes the drugs capecitabine (Xeloda) and oxaliplatin.

Display Name: XELOX Regimen

Label: XELOX Regimen

NCI Thesaurus Code: C63597 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1956962  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Xeloda-Oxaliplatin Regimen
XELOX Regimen
XELOX regimen

External Source Codes: 
PDQ Closed Trial Search ID 657267
PDQ Open Trial Search ID 657267 (check for NCI PDQ open clinical trial info)
UMLS CUI C1956962

Other Properties:
     Name Value (qualifiers indented underneath)
code C63597
Contributing_Source CTRP
DesignNote Source: Physician's Cancer Chemotherapy Manual 2006
Legacy_Concept_Name XELOX_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom